Literature DB >> 8956311

Seroprevalence of hepatitis E in hemodialysis patients in Turkey.

K Cengiz, E Ozyilkan, A M Coşar, M Günaydin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8956311     DOI： 10.1159/000189490

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  5 in total

1.  Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain.

Authors:  Maria Buti; Angela Domínguez; Pere Plans; Rossend Jardí; Mélani Schaper; Jordi Espuñes; Neus Cardeñosa; Francisco Rodríguez-Frías; Rafael Esteban; Antoni Plasència; Luis Salleras
Journal:  Clin Vaccine Immunol       Date:  2006-10-18

2.  Hepatitis E virus IgG seroprevalence in liver transplant patients: A retrospective single-center experience.

Authors:  Ferit Celik; Ali Senkaya; Nalan Gulsen Unal; Seymur Aslanov; Alper Uysal; Aysin Zeytinoglu; Ilker Turan; Murat Zeytunlu; Omer Ozutemiz; Ulus Salih Akarca; Zeki Karasu; Fulya Gunsar
Journal:  Hepatol Forum       Date:  2021-01-08

3.  The Prevalence of Hepatitis E Virus Infection in the Adult Turkish Population: A Systematic Review of the Literature and Prevalence Study in Blood Donors in Mersin Province.

Authors:  Orhan Sezgin; Serkan Yaraş; Seda Tezcan Ülger; Gönül Aslan; Eyyüp Naci Tiftik
Journal:  Turk J Gastroenterol       Date:  2021-09       Impact factor: 1.555

4.  Prevalence of anti-hepatitis E virus IgG antibodies in sera from hemodialysis patients in Tripoli, Lebanon.

Authors:  Mohamad Bachar Ismail; Imad Al Kassaa; Dima El Safadi; Sarah Al Omari; Hassan Mallat; Fouad Dabboussi; Monzer Hamze
Journal:  PLoS One       Date:  2020-05-18       Impact factor: 3.240

Review 5.  Hepatitis E virus infection in Turkey: a systematic review.

Authors:  Hakan Leblebicioglu; Resat Ozaras
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-05-02       Impact factor: 3.944
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.